Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro

References

• Aguzzi MS, Giampietri C, De Marchis F, Padula F, Gaeta R, Ragone G, Capogrossi MC, and Facchiano A. (2004). RGDS peptide induces caspase 8 and caspase 9 activation in human endothelial cells. Blood, 103, 4180–4187.
   PubMed Web of Science ®Google Scholar
• Arap W, Pasqualini R, Ruoslahti E. (1998). Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science, 279, 377–380.
   PubMed Web of Science ®Google Scholar
• Aris A, Villaverde A. (2000). Molecular organization of protein-DNA complexes for cell-targeted DNA delivery. Biochem Biophys Res Commun, 278, 455–461.
   PubMed Web of Science ®Google Scholar
• Baillie CT, Winslet MC, Bradley NJ. (1995). Tumour vasculature—a potential therapeutic target. Br J Cancer, 72, 257–267.
   PubMed Web of Science ®Google Scholar
• Baranska P, Jerczynska H, Pawlowska Z, Koziolkiewicz W, Cierniewski CS. (2005). Expression of integrins and adhesive properties of human endothelial cell line EA.hy 926. Cancer Genomics Proteomics, 2, 265–270.
   PubMedGoogle Scholar
• Brenner W, Gross S, Steinbach F, Horn S, Hohenfellner R, Thuroff JW. (2000). Differential inhibition of renal cancer cell invasion mediated by fibronectin, collagen IV and laminin. Cancer Lett, 155, 199–205.
   PubMed Web of Science ®Google Scholar
• Bronich TK, Nguyen HK, Eisenberg A, Kabanov AV. (2000). Recognition of DNA topology in reactions between plasmid DNA and cationic copolymers. J Am Chem Soc, 122, 8339–8343.
   Web of Science ®Google Scholar
• Burak Y, Ariel G, Andelman D. (2003). Onset of DNA aggregation in presence of monovalent and multivalent counterions. Biophys J, 85, 2100–2110.
   PubMed Web of Science ®Google Scholar
• Clements BA, Bai J, Kucharski C, Farrell LL, Lavasanifar A, Ritchie B, Ghahary A, Uludag H. (2006). RGD conjugation to polyethyleneimine does not improve DNA delivery to bone marrow stromal cells. Biomacromolecules, 7, 1481–1488.
   PubMed Web of Science ®Google Scholar
• Colin M, Harbottle RP, Knight A, Kornprobst M, Cooper RG, Miller AD, Trugnan G, Capeau J, Coutelle C, Brahimi-Horn MC. (1998). Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells. Gene Ther, 5, 1488–1498.
   PubMed Web of Science ®Google Scholar
• Dash PR, Read ML, Fisher KD, Howard KA, Wolfert M, Oupicky D, Subr V, Strohalm J, Ulbrich K, Seymour LW. (2000). Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin. J Biol Chem, 275, 3793–3802.
   PubMed Web of Science ®Google Scholar
• Enns A, Korb T, Schluter K, Gassmann P, Spiegel HU, Senninger N, Mitjans F, Haier J. (2005). Alphavbeta5-integrins mediate early steps of metastasis formation. Eur J Cancer, 41, 1065–1072.
   PubMed Web of Science ®Google Scholar
• Harvie P, Dutzar B, Galbraith T, Cudmore S, O’Mahony D, Anklesaria P, Paul R. (2003). Targeting of lipid-protamine-DNA (LPD) lipopolyplexes using RGD motifs. J Liposome Res, 13, 231–247.
   PubMed Web of Science ®Google Scholar
• Haubner R, Wester HJ, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman SL, Kessler H, Schwaiger M. (2001). Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med, 42, 326–336.
   PubMed Web of Science ®Google Scholar
• Houk BE, Hochhaus G, Hughes JA. (1999). Kinetic modeling of plasmid DNA degradation in rat plasma. AAPS PharmSci, 1, E9.
   PubMed Web of Science ®Google Scholar
• Houk BE, Martin R, Hochhaus G, Hughes JA. (2001). Pharmacokinetics of plasmid DNA in the rat. Pharm Res, 18, 67–74.
   PubMed Web of Science ®Google Scholar
• Hynes RO. (2002). Integrins: bidirectional, allosteric signaling machines. Cell, 110, 673–687.
   PubMed Web of Science ®Google Scholar
• Kim S, Bell K, Mousa SA, Varner JA. (2000). Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol, 156, 1345–1362.
   PubMed Web of Science ®Google Scholar
• Kim WJ, Yockman JW, Lee M, Jeong JH, Kim YH, Kim SW. (2005). Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis. J Control Release, 106, 224–234.
   PubMed Web of Science ®Google Scholar
• Kunath K, Merdan T, Hegener O, Haberlein H, Kissel T. (2003). Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J Gene Med, 5, 588–599.
   PubMed Web of Science ®Google Scholar
• Lai E, Van Zanten JH. (2001). Monitoring DNA/poly-l-lysine polyplex formation with time-resolved multiangle laser light scattering. Biophys J, 80, 864–873.
   PubMed Web of Science ®Google Scholar
• Lang SH, Clarke NW, George NJ, Testa NG. (1997). Primary prostatic epithelial cell binding to human bone marrow stroma and the role of alpha2beta1 integrin. Clin Exp Metastasis, 15, 218–227.
   PubMed Web of Science ®Google Scholar
• Mayoral R, Fernandez-Martinez A, Bosca L, Martin-Sanz P. (2005). Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells. Carcinogenesis, 26, 753–761.
   PubMed Web of Science ®Google Scholar
• Meerovitch K, Bergeron F, Leblond L, Grouix B, Poirier C, Bubenik M, Chan L, Gourdeau H, Bowlin T, Attardo G. (2003). A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagen. Vascul Pharmacol, 40, 77–89.
   PubMed Web of Science ®Google Scholar
• Mitra A, Mulholland J, Nan A, McNeill E, Ghandehari H, Line BR. (2005). Targeting tumor angiogenic vasculature using polymer-RGD conjugates. J Control Release, 102, 191–201.
   PubMed Web of Science ®Google Scholar
• Niven R, Pearlman R, Wedeking T, MacKeigan J, Noker P, Simpson-Herren L, Smith JG. (1998). Biodistribution of radiolabeled lipid-DNA complexes and DNA in mice. J Pharm Sci, 87, 1292–1299.
   PubMed Web of Science ®Google Scholar
• Oba M, Fukushima S, Kanayama N, Aoyagi K, Nishiyama N, Koyama H, and Kataoka K. (2007). Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins. Bioconjug Chem, 18, 1415–1423.
   PubMed Web of Science ®Google Scholar
• Osaka G, Carey K, Cuthbertson A, Godowski P, Patapoff T, Ryan A, Gadek T, Mordenti J. (1996). Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach. J Pharm Sci, 85, 612–618.
   PubMed Web of Science ®Google Scholar
• Oupicky D, Howard KA, Konak C, Dash PR, Ulbrich K, Seymour LW. (2000). Steric stabilization of poly-l-lysine/DNA complexes by the covalent attachment of semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]. Bioconjug Chem, 11, 492–501.
   PubMed Web of Science ®Google Scholar
• Oupicky D, Ogris M, Howard KA, Dash PR, Ulbrich K, Seymour LW. (2002a). Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol Ther, 5, 463–472.
   PubMed Web of Science ®Google Scholar
• Oupicky D, Parker AL, Seymour LW. (2002b). Laterally stabilized complexes of DNA with linear reducible polycations: strategy for triggered intracellular activation of DNA delivery vectors. J Am Chem Soc, 124, 8–9.
   PubMed Web of Science ®Google Scholar
• Pan H, Zheng Q, Guo X, Liu Y, Li C, Song Y. (2006). A RGD-containing oligopeptide (K)16GRGDSPC: a novel vector for integrin-mediated targeted gene delivery. J Huazhong Univ Sci Technol Med Sci, 26, 513–516.
   PubMedGoogle Scholar
• Ray S, Chattopadhyay N, Biswas N, Chatterjee A. (1999). Regulatory molecules in tumor metastasis. J Environ Pathol Toxicol Oncol, 18, 251–259.
   PubMedGoogle Scholar
• Rokhlin OW, Cohen MB. (1995). Expression of cellular adhesion molecules on human prostate tumor cell lines. Prostate, 26, 205–212.
   PubMed Web of Science ®Google Scholar
• Romanov VI, Goligorsky MS. (1999). RGD-recognizing integrins mediate interactions of human prostate carcinoma cells with endothelial cells in vitro. Prostate, 39, 108–118.
   PubMed Web of Science ®Google Scholar
• Ruoslahti E. (2002). Specialization of tumour vasculature. Nat Rev Cancer, 2, 83–90.
   PubMed Web of Science ®Google Scholar
• Ruponen M, Yla-Herttuala S, Urtti A. (1999). Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies. Biochim Biophys Acta, 1415, 331–341.
   PubMed Web of Science ®Google Scholar
• Schiffelers RM, Ansari A, Xu J, Zhou Q, Tang Q, Storm G, Molema G, Lu PY, Scaria PV, Woodle MC. (2004). Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res, 32, e149.
   PubMed Web of Science ®Google Scholar
• Shiras A, Bhosale A, Patekar A, Shepal V, Shastry P. (2002). Differential expression of CD44(S) and variant isoforms v3, v10 in three-dimensional cultures of mouse melanoma cell lines. Clin Exp Metastasis, 19, 445–455.
   PubMed Web of Science ®Google Scholar
• Smolarczyk R, Cichon T, Graja K, Hucz J, Sochanik A, Szala S. (2006). Antitumor effect of RGD-4C-GG-D(KLAKLAK)2 peptide in mouse B16(F10) melanoma model. Acta Biochim Pol, 53, 801–805.
   PubMed Web of Science ®Google Scholar
• Soundara Manickam D, Bisht HS, Wan L, Mao G, Oupicky D. (2005). Influence of TAT-peptide polymerization on properties and transfection activity of TAT/DNA polyplexes. J Control Release, 102, 293–306.
   PubMed Web of Science ®Google Scholar
• Suh W, Han SO, Yu L, Kim SW. (2002). An angiogenic, endothelial-cell-targeted polymeric gene carrier. Mol Ther, 6, 664–672.
   PubMed Web of Science ®Google Scholar
• Ustach CV, Taube ME, Hurst NJ Jr, Bhagat S, Bonfil RD, Cher ML, Schuger L, Kim HR. (2004). A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression. Cancer Res, 64, 1722–1729.
   PubMed Web of Science ®Google Scholar
• Varga CM, Hong K, Lauffenburger DA. (2001). Quantitative analysis of synthetic gene delivery vector design properties. Mol Ther, 4, 438–446.
   PubMed Web of Science ®Google Scholar
• Wiethoff CM, Smith JG, Koe GS, Middaugh CR. (2001). The potential role of proteoglycans in cationic lipid-mediated gene delivery. Studies of the interaction of cationic lipid-DNA complexes with model glycosaminoglycans. J Biol Chem, 276, 32806–32813.
   PubMed Web of Science ®Google Scholar
• Zhou QH, Miller DL, Carlisle RC, Seymour LW, Oupicky D. (2005). Ultrasound-enhanced transfection activity of HPMA-stabilized DNA polyplexes with prolonged plasma circulation. J Control Release, 106, 416–427.
   PubMed Web of Science ®Google Scholar